Parkwalk Advisors has invested an undisclosed sum in Cardiff ultrasound simulation technology developer MedaPhor through its Opportunities Fund.

ETH Zurich-founded cybersecurity business Xorlab focuses on thwarting email attacks through a combination of machine learning and advanced dynamic analysis.

ICL vascular implant spinout Veryan Medical has been bought by medical device firm Otsuka after raising $56m from investors including IP Group.

TU Dresden spinout DenovoMatrix hopes to commercialise a method for effectively cultivating stem cell production.

Vertical Venture Partners has joined university venture fund Highlander Venture Fund as an investor in UC Riverside-founded mosquito repellent developer Sensorygen.

Industrial analytics spinout Mondas is targeting energy applications and has already started testing at a local solar energy network.

Newly-launched Bern University of Applied Sciences spinout Threatray believes its automated malware detection design will improve upon existing approaches.

Agilent and Lam Research participated in a $30m series B for UCSF's DNA analysis spinout Mission Bio, whose existing shareholders include Stanford-StartX Fund.

Investors including co-founder and Harvard professor Timothy Springer scored exits as mRNA therapy developer Moderna floated in the largest biotech IPO of all time.

The tea product supplier has become the fourth business backed by University of Maryland Momentum Fund.